Bladder cancer ranks among the most common cancers globally. At diagnosis, 75% of
patients have non-muscle-invasive bladder cancer (NMIBC). Patients with low-risk NMIBC …

Bladder cancer is the fourth most common cancer in men and the 11th most common cancer
in woman accounting for 6.6% of all cancer cases. Approximately 70-75% bladder cancers …

BACKGROUND: A European Organisation for Research and Treatment of Cancer analysis
of multicentre trials found significant interinstitutional variability in recurrence rates at first …

Background Cystoscopy plays an important role in bladder cancer (BCa) diagnosis and
treatment, but its sensitivity needs improvement. Artificial intelligence has shown promise in …

Background Bladder cancer (BCa) can be divided into muscle‐invasive BCa (MIBC) and
non− muscle‐invasive BCa (NMIBC). Whether the tumor infiltrates the detrusor muscle is a …

Study Type–Therapy (cohort) Level of Evidence 2b What's known on the subject? and What
does the study add? Apart from bladder tumour multiplicity, size, stage, grade and presence …

Methods We update the previously published 2009 Canadian guidelines on the
management of NMIBC, emphasizing intravesical therapy. 18 We conducted a …

Background Clinical treatment decision making of bladder cancer (BCa) relies on the
absence or presence of muscle invasion and tumor staging. Deep learning (DL) is a novel …

Objectives To assess the clinical significance of repeat transurethral resection (reTUR) and
surgical margin status after en bloc resection of bladder tumour (ERBT) for pathological T1 …

This study aimed to develop a versatile automatic segmentation model of bladder cancer
(BC) on MRI using a convolutional neural network and investigate the robustness of …